| THURSDAY,
MARCH 22, 2001 |
10:00-12:00
 |
GLAUCOMA
Chairpersons:
J.S. Schuman, USA
S. Melamed, Israel |
Hall
A |
| 10:00 |
WELCOME
AND INTRODUCTION
S. Melamed, Israel
J.S. Schuman, USA |
|
| 10:15 |
IF
I HAD GLAUCOMA
D.L. Epstein, USA |
|
| 10:35 |
THE
CHALLENGES OF DEFINING GLAUCOMA AND ITS PROGRESSION
R.A. Hitchings, UK |
|
| 10:55 |
GLAUCOMA
IN THE DEVELOPING WORLD-GLAUCOMA AS A SURGICAL DISEASE
F.F. El Sayyad, Egypt |
|
| 11:15 |
THE
RATIONALE OF TREATING NORMAL TENSION GLAUCOMA
R. Brubaker, USA |
|
| 11:35 |
NEW
THERAPEUTIC MODALITIES - WHY DO WE NEED THEM?
V.P. Costa, Brazil |
|
| 12:00 |
Lunch
Break |
|
13:00-14:40
|
BEYOND
IOP: NEW TARGETS IN GLAUCOMA MANAGEMENT
Sponsored by Novartis Ophthalmics
Chairperson:
S. Melamed, Israel |
Hall
A |
| 13:00 |
WELCOME
AND INTRODUCTION
S. Melamed, Israel |
|
| 13:05 |
BEYOND
IOP: THE EMERGING ROLE OF ENDOTHELIN-1 IN THE PATHOGENESIS OF GLAUCOMA
J. Flammer, Switzerland |
|
| 13:20 |
THE
PATHOPHYSIOLOGICAL SIGNIFICANCE OF DOCOSANOIDS IN THE EYE
N. Bazan, USA |
|
| 13:35 |
UNOPROSTONE
ISOPROPYL: RECENT TRIAL DATA ON A NEW DOCOSANOID
J.P.L. Nordmann, France |
|
| 13:50 |
FROM
BENCH TO BEDSIDE: PRACTICAL USE OF UNOPROSTONE
J.S. Schuman, USA |
|
| 14:05 |
THE
EFFICACY AND SYSTEMATIC SAFETY OF A NOVEL ONCE-A-DAY TIMOLOL 0.1% GEL
FORMULATION. THE BENEFITS OF IMPROVED DRUG VEHICLE
H. Uusitalo, Finland |
|
| 14:15 |
A
NOVEL ONCE-A-DAY TIMOLOL 0.1% GEL FORMULATION HAS AN EQUIVALENT
IOP-LOWERING
EFFICACY TO TIMOLOL 0.5% SOLUTION
J.F. Rouland, France |
|
| 14:25 |
Discussion |
|
14:40-16:10
|
EXFOLIATION
SYNDROME AS A GLOBAL PROBLEM, A POTENTIALLY CURABLE DISEASE
Sponsored by the Lindberg Society
Chairperson: A. Tarkkanen, Finland |
Hall
A |
| 14:40 |
EXFOLIATION
SYNDROME AS A GLOBAL PROBLEM
A. Ringvold, Norway |
|
| 14:50 |
CLINICAL
FINDINGS
J.M. Liebmann, USA |
|
| 15:00 |
EXFOLIATION
SYNDROME: PATHOBIOLOGY AND CLINICAL-HISTOPATHOLOGIC CORRELATIONSU.
Schloetzer-Schrehardt, G.O.H. Naumann, Germany |
|
| 15:20 |
THEORIES
OF PATHOGENESIS
K.F. Damji, Canada |
|
| 15:30 |
TREATMENT
OF EXFOLIATIVE GLAUCOMA
R. Ritch, USA |
|
| 15:40 |
CATARACT
SURGERY IN EYES WITH EXFOLIATION SYNDROME
C. Zetterstroem, Sweden |
|
| 15:50 |
GLAUCOMA
IN EYES WITH EXFOLIATION SYNDROME
A. Konstas, Greece |
|
| 16:00 |
UNANSWERED
QUESTIONS AND FUTURE DIRECTIONS--PANEL DISCUSSION |
|
| 16:10 |
Coffee
Break |
|
16:40-18:40
|
SURGERY
I - NON PENETRATING GLAUCOMA SURGERY
Chairperson:
P.L Kaufman, USA
Co-Moderators:
R.G Carassa, Italy
G.K Krieglstein, Germany |
Hall
A |
|
16:40 |
OUTFLOW FACILITY AND MORPHOLOGY AFTER VISCOCANALOSTOMY IN RHESUS
MONKEYS
P.L. Kaufman, USA |
|
| 16:52 |
HOW
DOES NON-PENETRATING GLAUCOMA SURGERY WORK?
D.H. Johnson, USA |
|
| 17:04 |
VISCOCANALOSTOMY
3 YEARS FOLLOW UP
M. Wishart, H. Porooshani, T.J. Shergill, Warrington, UK |
|
| 17:11 |
DEEP
SCLERECTOMY WITH THE USE OF MITOMYCIN C
D.G. Andreanos, D. Papaconstantinou, J. Vergados, J. Chalkiadakis, G.
Georgopoulos, Greece |
|
| 17:18 |
MITOMYCIN
C (MMC) IN NON PENETRATING TRABECULAR SURGERY
P. Sourdilles, P.Y Santiago, France |
|
| 17:25 |
NONPENETRATING
DEEP SCLERECTOMY WITH OR WITHOUT ADJUNCTIVE MITOMYCIN
O. Geyer, Israel |
|
| 17:32 |
DOES
THE DISSECTION DEPTH AND THICKNESS OF THE DEEP SCLERAL FLAP INFLUENCE
THE INTRAOCULAR PRESSURE AFTER VISCOCANALOSTOMY?
T. Dietlein, Germany |
|
| 17:39 |
ND:YAG
GONIOPUNCTURE AFTER DEEP SCLERECTOMY
A. Mermoud, Switzerland |
|
| 17:46 |
FOURTEEN
YEARS FOLLOW-UP RESULTS OF NON PENETRATING DEEP SLERLIMBLECTOMY WITH
COLLAGENOPLASTY AND NEW NON-ABSORBAL COLLAGEN IMPLANT.
S. Anisimova, Russia |
|
| 17:53 |
COMPARISON
OF VISCOCANALOSTOMY AND TRABECULECTOMY AS PRIMARY PROCEDURE IN
UNCONTROLLED OPEN ANGLE GLAUCOMA - A PROSPECTIVE RANDOMIZED STUDY
C. Luke, T. Dietlein, P. Jacobi, W. Konen, G. Krieglstein, Germany |
|
| 18:00 |
3-YEAR
CHANGES IN LENS TRANSPARENCY UPON GLAUCOMA SURGERY: A COMPARISON BETWEEN
TRABECULECTOMY AND DEEP SCLERECTOMY
S.A. Gandolfi, L. Quaranta, S. Bettelli, L. Cimino, Italy |
|
| 18:07 |
NON-PENETRATING
DEEP SCLERECTOMY VS. TRABECULECTOMY: FEATURES OF POSTOPERATIVE OUTFLOW
T. Kozlova, J.G. Uzunian, A.B. Bessarabov, Russia |
|
| 18:14 |
DESCEMENT'S
MEMBRANE DETACHMENT BY HIGH MOLECULER WEIGHT SODIUM HYALURONATE DURING
VISCOCANALOSTOMY
O. Ocakoglu, C. Ustundag, K. Devranoglu, R. Yildirim, S. Ozkan, Turkey |
|
| 18:21 |
ENDOSCOPIC
NON-FILTERING SURGERY IN GLAUCOMA MANAGEMENT
P.C. Jacobi, T.S. Dietlein, G.K. Krieglstein, Germany |
|
| 18:28 |
MODERN
TECHNOLOGIES OF PRIMARY GLAUCOMA SURGERY
D. Ivanov, Russia |
|
| 18:35 |
Discussion |
|
16:40-18:20
|
GENETICS
AND EPIDEMIOLOGY
Chairperson:
R. Wilson, USA
Co-Moderators:
F. Lerner, Argentina
J.L Wiggs, USA |
Hall
B |
| 16:40 |
GENOMIC
SCREEN FOR ADULT ONSET GLAUCOMA SUSCEPTIBILITY GENES: FINE MAPPING OF
CANDIDATE REGIONS
R.R. Allingham, L.R. Bailey, J. August, E.A. Del Bono, B. Broomer, K.
Larocque, F. Lennon-Grahm, M. Pericak-Vance, M. Hauser, J.L. Haines, J.L.
Wiggs, USA |
|
| 16:50 |
PHENOTYPE/GENOTYPE
CORRELATION IN A FAMILY PEDIGREE WITH THE ARG433CYS MUTATION IN THE MYOC
GENE
V.P. Costa, Brazil |
|
| 17:00 |
THE
MANAGEMENT OF GLAUCOMA IN THE UNITED STATES ELDERLY POPULATION
A.L. Coleman, USA |
|
| 17:10 |
PREVALENCE
OF BLINDNESS FOR GLAUCOMA IN A POOR AREA OF BUENOS AIRES, ARGENTINA
D. Sivori, P. Vozza, F. Lerner, Argentina |
|
| 17:20 |
RATE
OF VISUAL FIELD PROGRESSION IN A GLAUCOMA FOLLOW UP STUDY IN ST. LUCIA,
WEST INDIES
O. Kosoko, M.R. Wilson, C. Enger, USA |
|
| 17:30 |
ECONOMIC
IMPACT OF CLINICAL TREATMENT OF GLAUCOMA ON FAMILAR INCOME OF
GLAUCOMATOUS OUTPATIENTS -GLAUCOMA AMBULATORY OF HOSPITAL DAS
CLÍNICAS , FACULTY OF MEDICIN, RIBEIRÃO PRETO -USP
C. Lauretti, Brazil |
|
| 17:40 |
PSUEDOEXPOLIATION
IN GLAUCOMA AND CATARACT PATIENTS
K. Blazevska Buzarovska, Macedonia |
|
| 17:50 |
Discussion |
|
SCIENTIFIC PROGRAM
